The COVID-19 Immunity Task Force will study the prevalence of COVID-19 antibodies among Canadians over 50 years old; Dr. Mona Nemer is appointed to a second term as Chief Science Officer, and digital health technology continues to accelerate in Canada.
Topic: Alzheimer's disease
Researchers fear National Dementia Strategy may falter
One year after the launch of Canada’s first national dementia strategy, the optimism surrounding the announcement is fading. Funding is beginning to trickle out in support of dementia awareness programs. But plans to implement the strategy, and the funding needed to fully support implementation, have yet to materialize.